Innovation Pharmaceuticals Inc. (IPIX)

IPIX Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2023	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019
Net Income	-2.62	-3.17	-7.04	-13.87	-6.65	-8.68
Depreciation & Amortization	0.37	0.37	0.38	0.38	0.4	0.37
Loss (Gain) From Sale of Assets	-	-	-	-	-	-0.04
Asset Writedown & Restructuring Costs	-	-	0.14	-	0.64	0.15
Loss (Gain) on Equity Investments	0.21	0.17	0.02	-	-	-
Stock-Based Compensation	0.03	0.21	0.58	0.18	0.43	1.08
Other Operating Activities	-	-	0.01	4.66	1.14	2.03
Change in Accounts Payable	0.1	0.42	0	0.52	-0.08	-1.06
Change in Other Net Operating Assets	-0.09	-0.11	-0.38	-1.37	-0.03	-0.19
Operating Cash Flow	-1.99	-2.11	-6.28	-9.5	-4.16	-6.33
Sale of Property, Plant & Equipment	-	-	-	-	-	0.04
Sale (Purchase) of Intangibles	-0.06	-0.06	-0.08	-0.07	-0.09	-0.09
Investment in Securities	-	-	-4	-	-	-
Investing Cash Flow	-0.06	-0.06	-4.08	-0.07	-0.09	-0.05
Short-Term Debt Repaid	-	-0.04	-1.03	-0.2	-	-
Total Debt Repaid	-0.03	-0.04	-1.03	-0.2	-	-
Net Debt Issued (Repaid)	-0.01	-0.04	-1.03	-0.2	-	-
Issuance of Common Stock	-	-	0.02	4.6	3.04	-
Repurchase of Common Stock	-	-	-	-0.67	-0.06	-0.09
Preferred Dividends Paid	-0.05	-0.09	-	-	-	-
Dividends Paid	-0.05	-0.09	-	-	-	-
Financing Cash Flow	-0.05	-0.12	3.97	13.74	9.69	4.53
Net Cash Flow	-2.1	-2.29	-6.39	4.18	5.44	-1.85
Free Cash Flow	-1.99	-2.11	-6.28	-9.5	-4.16	-6.33
Free Cash Flow Margin	-	-	-34888.89%	-	-982.51%	-
Free Cash Flow Per Share	-0.00	-0.00	-0.01	-0.03	-0.02	-0.04
Cash Interest Paid	-	0.01	0.06	0.06	0.22	0.14
Levered Free Cash Flow	-0.99	-0.93	-3.62	-9	-2.41	-5.11
Unlevered Free Cash Flow	-0.95	-0.9	-3.55	-5.96	-2.25	-3.74
Change in Net Working Capital	-0.18	-0.42	0.21	0.82	0.09	1.17

Updated Nov 20, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.